Biologics Archives - Page 17 of 88 - Becker’s Spine Review

Royal Biologics launches new platelet-rich plasma system for orthopedics

Orthobiologics company Royal Biologics has commercially launched a new platelet-rich plasma system, Bioincyte.

3-year data shows efficacy of bone marrow aspirate for spine treatment

A three-year study of Creative Medical Technology Holdings' StemSpine procedure found it was effective for addressing chronic lower back pain.

2-year data on cell therapy for degenerative disc disease is out: 5 things to know

Orthobiologics company DiscGenics shared data supporting its IDCT (rebonuputemcel) allogeneic discogenic progenitor cell therapy for lumbar degenerative disc disease.

Apex Biologix appoints new CEO

Apex Biologix has chosen Jim Rogers to be the company's next CEO.

ChitogenX's fiscal year Q3 report: 5 notes

ChitogenX, formerly OrthoRTI, shared its third quarter results for fiscal year 2023.

5 leading headlines in regenerative medicine

Here are five top-read Becker's headlines on orthobiologics and regenerative medicine in 2022:

Data supports Orthofix's cellular bone allograft in lumbar fusions

A study published in Neurology International found fusion rates of 98.6 percent with Orthofix's Trinity Elite cellular bone allograft, the devicemaker said Dec. 22.

California orthopedic center adds PRP knee treatment

NorthBay Health Orthopedics in Vacaville, Calif. added platelet-rich plasma injections for knee injuries, according to a Dec. 18 announcement in the Daily Republic.

5 developments in orthobiologics

Here are five updates in the orthobiologics industry since Oct. 17:

Hawaii hospital 1st in state to use BEAR implant

Shriners Children's Hawaii in Honolulu is the first hospital in the state to use the Bridge-Enhanced ACL Restoration, or BEAR, implant, ABC affiliate KITV reported Nov. 23.